Cited by 1,082Antibiotic Resistance in BacteriaDrug Transport and Resistance MechanismsBacterial Genetics and Biotechnology

The DOI matches its Crossref record; 733 of the 733 references it cites were found in a registry or an index.

Efflux-mediated antimicrobial resistance

Poole, Keith·2005·Journal of Antimicrobial Chemotherapy

DOI 10.1093/jac/dki171

Open this paper in CoChat — free account

Abstract

Antibiotic resistance continues to plague antimicrobial chemotherapy of infectious disease. And while true biocide resistance is as yet unrealized, in vitro and in vivo episodes of reduced biocide susceptibility are common and the history of antibiotic resistance should not be ignored in the development and use of biocidal agents. Efflux mechanisms of resistance, both drug specific and multidrug, are important determinants of intrinsic and/or acquired resistance to these antimicrobials, with some accommodating both antibiotics and biocides. This latter raises the spectre (as yet generally unrealized) of biocide selection of multiple antibiotic-resistant organisms. Multidrug efflux mechanisms are broadly conserved in bacteria, are almost invariably chromosome-encoded and their expression in many instances results from mutations in regulatory genes. In contrast, drug-specific efflux mechanisms are generally encoded by plasmids and/or other mobile genetic elements (transposons, integrons) that carry additional resistance genes, and so their ready acquisition is compounded by their association with multidrug resistance. While there is some support for the latter efflux systems arising from efflux determinants of self-protection in antibiotic-producing Streptomyces spp. and, thus, intended as drug exporters, increasingly, chromosomal multidrug efflux determinants, at least in Gram-negative bacteria, appear not to be intended as drug exporters but as exporters with, perhaps, a variety of other roles in bacterial cells. Still, given the clinical significance of multidrug (and drug-specific) exporters, efflux must be considered in formulating strategies/approaches to treating drug-resistant infections, both in the development of new agents, for example, less impacted by efflux and in targeting efflux directly with efflux inhibitors.

Integrity signals

Registry

Crossref · 10.1093/jac/dki171

Cites

733 of 733 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Items 601–733 of 733

Chloroquinolines block antibiotic efflux pumps in antibiotic-resistant Enterobacter aerogenes isolates
Ghisalberti, D., Mahamoud, A., Chevalier, J., Baitiche, M., de Martino, M., Pagès, J., & Barbe, J. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.03.010 · Cited by 39
Distribution of Tetracycline Resistance Genes in Actinobacillus pleuropneumoniae Isolates from Spain
Blanco, M., Gutiérrez-Martín, C. B., Ferri, E. F. R., Roberts, M. C., & Navas, J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.702-708.2006 · Cited by 39
High Occurrence of Simultaneous Mutations in Target Enzymes and MtrRCDE Efflux System in Quinolone-Resistant Neisseria gonorrhoeae
Dewi, B. E., AKIRA, S., Hayashi, H., & Ba‐Thein, W. (2004) · Sexually Transmitted Diseases · doi:10.1097/00007435-200406000-00007 · Cited by 38
Distribution of Subclasses mefA and mefE of the mefA Gene among Clinical Isolates of Macrolide-Resistant (M-Phenotype) Streptococcus pneumoniae , Viridans Group Streptococci, and Streptococcus pyogenes
Ardanuy, C., Tubau, F., Liñares, J., Domínguez, M. Á., Pallarés, R., & Martín, R. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.827-829.2005 · Cited by 38
A Self-defense Gene Homologous to Tetracycline Effluxing Gene Essential for Antibiotic Production inStreptomyces aureofaciens
Dairi, T., Aisaka, K., Katsumata, R., & Hasegawa, M. (1995) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.59.1835 · Cited by 38
Electrical enhancement of Streptococcus gordonii biofilm killing by gentamicin
Wattanakaroon, W., & Stewart, P. S. (2000) · Archives of Oral Biology · doi:10.1016/s0003-9969(99)00132-6 · Cited by 37
Increased Expression of Two Multidrug Transporter-Like Genes Is Associated with Ethidium Bromide and Ciprofloxacin Resistance in Mycoplasma hominis
Raherison, S., Gonzalez, P., Renaudin, H., Charron, A., Bébéar, C., & Bébéar, C. M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.421-424.2005 · Cited by 37
Biocide abuse and antimicrobial resistance: being clear about the issues
Gilbert, P. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf071 · Cited by 37
Emergence of a fluoroquinolone-resistant strain of Streptococcus pneumoniae in England
Johnson, A. P. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg469 · Cited by 37
Regulation of the expression of the CmeABC efflux pump inCampylobacter jejuni: identification of a point mutation abolishing the binding of the CmeR repressor in anin vitro-selected multidrug-resistant mutant
Cagliero, C., Maurel, M. C., Cloeckaert, A., & Payot, S. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2006.00558.x · Cited by 36
Origin of tetracycline efflux proteins: conclusions from nucleotide sequence analysis
Sheridan, R. P., & Chopra, I. (1991) · Molecular Microbiology · doi:10.1111/j.1365-2958.1991.tb00763.x · Cited by 36
Clonal Diversity among Streptogramin A-Resistant Staphylococcus aureus Isolates Collected in French Hospitals
Haroche, J., Morvan, A., Davi, M., Allignet, J., Bimet, F., & Solh, N. E. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.2.586-591.2003 · Cited by 36
Accumulation of garenoxacin by Bacteroides fragilis compared with that of five fluoroquinolones
Ricci, V. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg418 · Cited by 36
Biocide Usage in the Domestic Setting and Concern about Antibacterial and Antibiotic Resistance
Gilbert, P., & McBain, A. J. (2001) · Journal of Infection · doi:10.1053/jinf.2001.0853 · Cited by 35
4-alkoxy and 4-thioalkoxyquinoline derivatives as chemosensitizers for the chloramphenicol-resistant clinical Enterobacter aerogenes 27 strain
Gallo, S. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00215-2 · Cited by 35
The newer fluoroquinolones
O’Donnell, J. A., & Gelone, S. P. (2004) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2004.04.011 · Cited by 35
Antibiotic resistance: a view from the prescriber
Finch, R. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro1049 · Cited by 34
Effect of an Efflux Pump Inhibitor on the Function of the Multidrug Efflux Pump CmeABC and Antimicrobial Resistance in Campylobacter
Martinez, A., & Lin, J. (2006) · Foodborne Pathogens and Disease · doi:10.1089/fpd.2006.3.393 · Cited by 34
The Macrolide-Bacterium Interaction and Its Biological Basis
Goldman, R. C., & Scaglione, F. (2004) · Current Drug Targets - Infectious Disorders · doi:10.2174/1568005043340812 · Cited by 34
Distribution of streptogramin resistance determinants among Enterococcus faecium from a poultry production environment of the USA
Hayes, J. R., Wagner, D. D., English, L., Carr, L. E., & Joseph, S. W. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh491 · Cited by 34
Mechanisms of beta-lactam resistance in Pseudomonas aeruginosa: prevalence of OprM-overproducing strains in a French multicentre study (1997)
Cavallo, J.-D. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf186 · Cited by 34
In Vitro Microbiological Characterization of a Novel Azalide, Two Triamilides and an Azalide Ketal against Bovine and Porcine Respiratory Pathogens
NORCIA, L. J. L., Silvia, A. M., Santoro, S. L., Retsema, J., Letavic, M. A., Bronk, B. S., Lundy, K. M., Yang, B. V., Evans, N. A., & HAYASHI, S. F. (2004) · The Journal of Antibiotics · doi:10.7164/antibiotics.57.280 · Cited by 34
Prevalence and Molecular Analysis of Macrolide and Fluoroquinolone Resistance among Isolates of Streptococcus pneumoniae Collected during the 2000-2001 PROTEKT US Study
Brown, S. D., Farrell, D. J., & Morrissey, I. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.11.4980-4987.2004 · Cited by 34
Evolution of erythromycin resistance in Streptococcus pneumoniae in Italy
Monaco, M., Camilli, R., D’Ambrosio, F., Grosso, M. D., & Pantosti, A. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh551 · Cited by 34
Plasmid-mediated florfenicol and ceftriaxone resistance encoded by thefloRandblaCMY-2genes inSalmonella entericaserovars Typhimurium and Newport isolated in the United States
Doublet, B., Carattoli, A., Whichard, J. M., White, D. G., Baucheron, S., Chaslus-Dancla, E., & Cloeckaert, A. (2004) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2004.tb09496.x · Cited by 34
Characterization of the antiseptic-resistance geneqacEΔ1isolated from clinical and environmental isolates ofVibrio parahaemolyticusandVibrio choleraenon-O1
Kazama, H., Hamashima, H., Sasatsu, M., & Arai, T. (1999) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1999.tb13593.x · Cited by 33
Increase in MICs of ciprofloxacin in vivo in two closely related clinical isolates of Enterobacter cloacae
Linde, H. ‐., Notka, F., Irtenkauf, C., Decker, J., Wild, J., Niller, H. H., Heisig, P., & Lehn, N. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.4.625 · Cited by 33
A Multiwell Assay to Isolate Compounds Inhibiting the Assembly of the Prokaryotic RNA Polymerase
André, E., Bastide, L., Villain-Guillot, P., Latouche, J., Rouby, J., & Léonetti, J. (2004) · Assay and Drug Development Technologies · doi:10.1089/adt.2004.2.629 · Cited by 32
Frequency and Genetic Characterization of Multidrug-Resistant Mutants of Staphylococcus aureus after Selection with Individual Antiseptics and Fluoroquinolones.
Noguchi, N., Tamura, M., Narui, K., Wakasugi, K. O., & Sasatsu, M. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.1129 · Cited by 32
In vitro fluoroquinolone-resistant mutants of Salmonella enterica serotype Enteritidis: analysis of mechanisms involved in resistance
Soto, S. M. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00241-3 · Cited by 32
Introduction of a norA Promoter Region Mutation into the Chromosome of a Fluoroquinolone-Susceptible Strain of Staphylococcus aureus Using Plasmid Integration
Kaatz, G. W., Seo, S. M., & Foster, T. J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.9.2222 · Cited by 32
Increased Prevalence of Erythromycin Resistance in Streptococci: Substantial Upsurge in Erythromycin-Resistant M Phenotype in Streptococcus pyogenes (1979-1998) but Not in Streptococcus pneumoniae (1985-1999) in Taiwan
Hsueh, P., Teng, L., Lee, L., Yang, P., Ho, S., Lue, H., & Luh, K. (2002) · Microbial Drug Resistance · doi:10.1089/10766290252913728 · Cited by 32
Antistreptococcal Activity of Telithromycin Compared with Seven Other Drugs in Relation to Macrolide Resistance Mechanisms in Russia
Kozlov, R. S., Bogdanovich, T., Appelbaum, P. C., Ednie, L. M., Stratchounski, L. S., Jacobs, M. R., & Bozdoğan, B. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.2963-2968.2002 · Cited by 32
Type II topoisomerase mutations in Bacillus anthracis associated with high-level fluoroquinolone resistance
Bast, D. J. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh294 · Cited by 32
Aminoglycoside Adaptive Resistance
Karlowsky, J. A., Zelenitsky, S. A., & Zhanel, G. G. (1997) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1997.tb03063.x · Cited by 32
The changing nature of aminoglycoside resistance mechanisms and the role of isepamicin--a new broad-spectrum aminoglycoside. The Aminoglycoside Resistance Study Groups.
Miller, G. H., Sabatelli, F., Naples, L., Hare, R. S., & Kj, S. (1995) · PubMed · Cited by 32
Fluoroquinolones as Chemotherapeutics Against Mycobacterial Infections
Jacobs, M. R. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383296 · Cited by 31
In Vitro Susceptibility Testing Versus In Vivo Effectiveness
Stratton, C. W. (2006) · Medical Clinics of North America · doi:10.1016/j.mcna.2006.07.003 · Cited by 31
Enhanced active efflux, repression of porin synthesis and development of Mar phenotype by diazepam in two enterobacteria strains
Tavío, M. M., Vilà, J., Perilli, M., Casañas, L. T., Maciá, L., Amicosante, G., & de Anta, M. T. J. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45613-0 · Cited by 31
MarA-Like Regulator of Multidrug Resistance in Yersinia pestis
Udani, R., & Levy, S. B. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00015-06 · Cited by 31
The origin of the antiseptic-resistance gene ebr in Staphylococcus aureus.
Sasatsu, M., Shirai, Y., Hase, M., Noguchi, N., Kono, M., Behr, H., Freney, J., & Arai, T. (1995) · PubMed · Cited by 30
Ketolides: an emerging treatment for macrolide-resistant respiratory infections, focusing on S. pneumoniae
Zhanel, G. G., Hisanaga, T., Nichol, K. A., Wierzbowski, A. K., & Hoban, D. J. (2003) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.8.2.297 · Cited by 30
Molecular characterization of class 1 integrons from Irish thermophilic Campylobacter spp.
O’Halloran, F. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh193 · Cited by 30
Activities of Different Fluoroquinolones against Bacillus anthracis Mutants Selected In Vitro and Harboring Topoisomerase Mutations
Grohs, P., Podglajen, I., & Gutmann, L. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.3024-3027.2004 · Cited by 30
Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii
Navia, M. M., Ruiz, J., Ribera, A., de Anta, M. T. J., & Vilà, J. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.6.743 · Cited by 30
Topoisomerase Targeting with and Resistance to Gemifloxacin in Staphylococcus aureus
İnce, D., Zhang, X., Silver, L. C., & Hooper, D. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.274-282.2003 · Cited by 29
Role of the MexXY multidrug efflux pump in moderate aminoglycoside resistance inPseudomonas aeruginosaisolates fromPseudomonasmastitis
Chuanchuen, R., Wannaprasat, W., Ajariyakhajorn, K., & Schweizer, H. P. (2008) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2008.00051.x · Cited by 29
Efflux of chloramphenicol by the CmlA1 protein
George, A. M., & Hall, R. M. (2002) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2002.tb11133.x · Cited by 29
The ubiquitous ThrE family of putative transmembrane amino acid efflux transporters
Yen, M., Tseng, Y.-H., Simic, P., Sahm, H., Eggeling, L., & Saier, M. H. (2002) · Research in Microbiology · doi:10.1016/s0923-2508(01)01281-5 · Cited by 29
Drug Efflux and parC Mutations Are Involved in Fluoroquinolone Resistance in Viridans Group Streptococci
Ferrándiz, M.-J., Oteo, J., Aracil, B., Gómez-Garcés, J. L., & de la Campa, A. G. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.10.2520 · Cited by 29
Relationship between mutations in the DNA gyrase and topoisomerase IV genes and nadifloxacin resistance in clinically isolated quinolone-resistant Staphylococcus aureus
Oizumi, N., Kawabata, S., Hirao, M., Watanabe, K., Okuno, S., Fujiwara, T., & Kikuchi, M. (2001) · Journal of Infection and Chemotherapy · doi:10.1007/s101560100034 · Cited by 28
Thecmegene ofClostridium difficileconfers multidrug resistance inEnterococcus faecalis
Lebel, S., Bouttier, S., & Lambert, T. (2004) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2004.tb09742.x · Cited by 28
Characterization of florfenicol resistance among calf pathogenic Escherichia coli
Du, X., Xia, C., Shen, J., Wu, B., & Shen, Z. (2004) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2004.tb09645.x · Cited by 28
Mechanism of quinolone resistance in anaerobic bacteria
Oh, H., & Edlund, C. (2003) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2003.00725.x · Cited by 27
Inactivation of the putative tetracycline resistance gene HP1165 in Helicobacter pylori led to loss of inducible tetracycline resistance
Li, Y., & Dannelly, H. K. (2006) · Archives of Microbiology · doi:10.1007/s00203-006-0093-9 · Cited by 27
Macrolide and Ketolide Resistance with Streptococcus pneumoniae
Doern, G. V. (2006) · Medical Clinics of North America · doi:10.1016/j.mcna.2006.07.010 · Cited by 27
Multidrug resistant phenotype of Bacillus subtilis spontaneous mutants isolated in the presence of puromycin and lincomycin
Murata, M., Ohno, S., Kumano, M., Yamane, K., & Ohki, R. (2003) · Canadian Journal of Microbiology · doi:10.1139/w03-014 · Cited by 26
Interaction of the MexA and MexB Components of the MexAB-OprM Multidrug Efflux System of Pseudomonas aeruginosa : Identification of MexA Extragenic Suppressors of a T578I Mutation in MexB
Nehme, D., & Poole, K. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.10.4375-4378.2005 · Cited by 26
Self-citation
Prevalence of Erythromycin-, Tetracycline-, and Aminoglycoside-Resistance Genes in Methicillin-Resistant Staphylococcus aureus in Hospitals in Tokyo and Kumamoto
Sekiguchi, J., Fujino, T., Saruta, K., Konosaki, H., Nishimura, H., Kawana, A., Kudo, K., Kondo, T., Yazaki, Y., Kuratsuji, T., et al. (2004) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2004.74 · Cited by 26
Incidence and mechanisms of aminoglycoside resistance inPseudomonas aeruginosa serotype O11 isolates
Kettner, M., Kallová, J., Hletková, M., & Milosovic, P. (1995) · Infection · doi:10.1007/bf01713571 · Cited by 25
Characterization of florfenicol resistance among calf pathogenic Escherichia coli
Du, X. (2004) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2004.05.013 · Cited by 25
In Vitro Activities of Garenoxacin (BMS-284756) against Streptococcus pneumoniae , Viridans Group Streptococci, and Enterococcus faecalis Compared to Those of Six Other Quinolones
Grohs, P., Houssaye, S., Aubert, A., Gutmann, L., & Varon, E. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3542-3547.2003 · Cited by 25
Telithromycin activity is reduced by efflux in Streptococcus pyogenes
Cantón, R., Mazzariol, A., Morosini, M.-I., Baquero, F., & Cornaglia, G. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki033 · Cited by 25
Production of the cryptic EefABC efflux pump in Enterobacter aerogenes chloramphenicol-resistant mutants
Masi, M. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl139 · Cited by 24
Activity of Gemifloxacin against Quinolone-Resistant Streptococcus pneumoniae Strains In Vitro and in a Mouse Pneumonia Model
Azoulay-Dupuis, E., Bédos, J. P., Mohler, J., Moine, P., Cherbuliez, C., Peytavin, G., Fantin, B., & Köhler, T. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1046-1054.2005 · Cited by 24
A Resistance-Nodulation-Cell Division Family Xenobiotic Efflux Pump in an Obligate Anaerobe, Porphyromonas gingivalis
Ikeda, T., & Yoshimura, F. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.10.3257-3260.2002 · Cited by 24
Inability of L22 ribosomal protein alteration to increase macrolide MICs in the absence of efflux mechanism in Haemophilus influenzae HMC-S
Peric, M. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh364 · Cited by 24
In Vitro and In Vivo Antibacterial Activities of the Tricyclic Ketolide TE-802 and Its Analogs
ONO, T., Kashimura, M., Suzuki, K., Oyauchi, R., Miyachi, J., Ikuta, H., Kawauchi, H., Akashi, T., Asaka, T., & Morimoto, S. (2004) · The Journal of Antibiotics · doi:10.7164/antibiotics.57.518 · Cited by 24
Mechanism of amikacin resistance in Pseudomonas aeruginosa isolates from patients with cystic fibrosis
Hurley, J. C., Miller, G. H., & Smith, A. L. (1995) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(95)00138-6 · Cited by 23
The efflux pump inhibitor Phe-Arg-beta-naphthylamide does not abolish the activity of the Stenotrophomonas maltophilia SmeDEF multidrug efflux pump
Sánchez, P. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg181 · Cited by 23
A Three-Dimensional Model for the Substrate Binding Domain of the Multidrug ATP Binding Cassette Transporter LmrA
Ecker, G. F., Pleban, K., Kopp, S., Csaszar, E., Poelarends, G. J., Putman, M., Kaiser, D., Konings, W. N., & Chiba, P. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.001420 · Cited by 23
Rapid identification of mutations in a multidrug efflux pump in Pseudomonas aeruginosa
Jalal, S., Wretlind, G., Gotoh, N., & Wretlind, B. (1999) · Apmis · doi:10.1111/j.1699-0463.1999.tb01516.x · Cited by 23
Biocide Usage in the Domestic Setting and Concern about Antibacterial and Antibiotic Resistance
Gilbert, P., & McBain, A. J. (2001) · Journal of Infection · doi:10.1016/s0163-4453(01)90853-9 · Cited by 23
Genomics, life style and molecular architecture
Ramos, J.-L. (2004) · Medical Entomology and Zoology · Cited by 22
Increase of Macrolide-Resistant Streptococcus pneumoniae-Expressing mefE or ermB Gene in the Nasopharynx among Children with Otitis Media
Hotomi, M., Billal, D. S., Shimada, J., Suzumoto, M., Yamauchi, K., Fujihara, K., & Yamanaka, N. (2005) · The Laryngoscope · doi:10.1097/01.mlg.0000154740.48314.d5 · Cited by 22
Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis
Saito, R. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl297 · Cited by 22
Macrolide resistance in Streptococci and Haemophilus influenzae
Bozdoğan, B., & Appelbaum, P. C. (2004) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2004.03.006 · Cited by 22
In vitro activity of older and newer fluoroquinolones against efflux-mediated high-level ciprofloxacin-resistant Streptococcus pneumoniae
Daporta, M. T., Bellido, J. L. M., Guirao, G. Y., Hernández, M. S., & Garcı́a-Rodrı́guez, J. Á. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.01.012 · Cited by 21
Resistance to a minoglycosides in Pseudomonas
Groups, A. R. S. (1994) · Trends in Microbiology · doi:10.1016/0966-842x(94)90609-2 · Cited by 20
Genotyping of Streptococcus pneumoniae and Haemophilus influenzae Isolated from Paired Middle Ear Fluid and Nasopharynx by Pulsed-Field Gel Electrophoresis
Hotomi, M., Yamanaka, N., Billal, D. S., Sakai, A., Yamauchi, K., Suzumoto, M., Takei, S., Yasui, N., Moriyama, S., & Kuki, K. (2004) · ORL · doi:10.1159/000081119 · Cited by 20
Prediction and classification of protein functions
Ruepp, A., & Mewes, H. (2006) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2006.06.011 · Cited by 20
Molecular Characterization of Clinical Streptococcus pneumoniae Isolates with Reduced Susceptibility to Fluoroquinolones Emerging in Italy
Montanari, M. P., Tili, E., Cochetti, I., Mingoia, M., Manzin, A., & Varaldo, P. E. (2004) · Microbial Drug Resistance · doi:10.1089/mdr.2004.10.209 · Cited by 20
Novel Ciprofloxacin-Resistant, Nalidixic Acid-Susceptible Mutant of Staphylococcus aureus
Piddock, L. J. V., Jin, Y., Webber, M. A., & Everett, M. J. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2276-2278.2002 · Cited by 20
Association of resistance to trimethoprim/sulphamethoxazole, chloramphenicol and quinolones with changes in major outer membrane proteins and lipopolysaccharide in Burkholderia cepacia
Rajyaguru, J. M. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.6.803 · Cited by 20
DX-619, a Novel Des-Fluoro(6) Quinolone Manifesting Low Frequency of Selection of Resistant Staphylococcus aureus Mutants: Quinolone Resistance beyond Modification of Type II Topoisomerases
Strahilevitz, J., Truong, Q. C., & Hooper, D. C. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.12.5051-5057.2005 · Cited by 20
The importance of active efflux systems in the quinolone resistance of clinical isolates of Salmonella spp
Escribano, I., Rodrı́guez, J. C., Cebrián, L., & Royo, G. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.05.004 · Cited by 20
Intrinsic and selected resistance to antibiotics binding the ribosome: analyses of Brucella 23S rrn, L4, L22, EF-Tu1, EF-Tu2, efflux and phylogenetic implications.
Halling, S. M., & Jensen, A. E. (2006) · BMC Microbiology · doi:10.1186/1471-2180-6-84 · Cited by 19
Clinical challenges of nosocomial infections caused by antibiotic-resistant pathogens in pediatrics
Pong, A. L., & Bradley, J. S. (2004) · Seminars in Pediatric Infectious Diseases · doi:10.1053/j.spid.2004.01.005 · Cited by 19
Characterization of an Escherichia coli O157:H7 marR mutant
Yaron, S. (2003) · International Journal of Food Microbiology · doi:10.1016/s0168-1605(02)00547-0 · Cited by 19
Resistance to Oleandomycin in Streptomyces antibioticus, the Producer Organism
Fierro, J. F., Hardisson, C., & Salas, J. A. (1987) · Microbiology · doi:10.1099/00221287-133-7-1931 · Cited by 19
Levofloxacin: update and perspectives on one of the original ‘respiratory quinolones’
Fish, D. N. (2003) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.1.3.371 · Cited by 19
Gene lmrB of Corynebacterium glutamicum Confers Efflux-mediated Resistance to Lincomycin
Kim, H. J., Kim, Y., Lee, M., & Lee, H.-S. (2001) · Molecules and Cells · doi:10.1016/s1016-8478(23)17069-5 · Cited by 19
Prevalence and Mechanisms of Aminoglycoside Resistance
Phillips, I. R., King, A., & Shannon, K. P. (1988) · Cited by 19
Phage types, ribotypes and tetracycline resistance genes of Salmonella enterica subsp. enterica serovar Typhimurium strains isolated from different origins in Italy
Pasquali, F., Cesare, A. D., Ricci, A., Kehrenberg, C., Schwarz, Š., & Manfreda, G. (2004) · Veterinary Microbiology · doi:10.1016/j.vetmic.2004.07.007 · Cited by 18
Bacterial Multidrug Resistance Mediated by a Homologue of the Human Multidrug Transporter P‐glycoprotein
Konings, W. N., & Poelarends, G. J. (2002) · IUBMB Life · doi:10.1080/15216540212646 · Cited by 18
A common clone of erythromycin-resistant Streptococcus pneumoniae in Greece and the UK
Fotopoulou, N., Tassios, P. T., Beste, D. J. V., Ioannidou, S., Efstratiou, A., Lawrence, E. R., Papaparaskevas, J., George, R. C., & Legakis, N. J. (2003) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2003.00689.x · Cited by 18
Lincomycin Resistance Mutations in Two Regions Immediately Downstream of the −10 Region of lmr Promoter Cause Overexpression of a Putative Multidrug Efflux Pump in Bacillus subtilis Mutants
Kumano, M., Fujita, M., Nakamura, K., Murata, M., Ohki, R., & Yamane, K. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.432-435.2003 · Cited by 18
Molecular Epidemiology and Prevalence of Macrolide Efflux Genes mef (A) and mef (E) in Streptococcus pneumoniae Obtained in Canada from 1997 to 2002
Wierzbowski, A. K., Swedlo, D., Boyd, D. A., Mulvey, M. R., Nichol, K. A., Hoban, D. J., & Zhanel, G. G. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1257-1261.2005 · Cited by 18
Synthesis and antibacterial activity of novel C12 ethyl ketolides
Burger, M. T., Hiebert, C., Seid, M., Chu, D. T. W., Barker, L., Langhorne, M., Shawar, R. M., Kidney, J., Desai, M. C., & Plattner, J. J. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.04.032 · Cited by 17
What do Proton Motive Force Driven Multidrug Resistance Transporters Have in Common?
Mazurkiewicz, P., Driessen, A. J. M., & Konings, W. N. (2005) · Current Issues in Molecular Biology · doi:10.21775/cimb.007.007 · Cited by 16
The gene of confers multidrug resistance in
Lebel, S., Bouttier, S., & Lambert, T. (2004) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2004.07.022 · Cited by 16
Characterization of Salmonella spp. Mutants with Reduced Fluoroquinolone Susceptibility: Importance of Efflux Pump Mechanisms
Cebrián, L., Rodrı́guez, J. C., Escribano, I., & Royo, G. (2005) · Chemotherapy · doi:10.1159/000084417 · Cited by 16
Efflux Pumps
Poole, K. (2004) · Springer eBooks · doi:10.1007/978-1-4419-9086-0_21 · Cited by 16
Self-citation
Homology model of the multidrug transporter LmrA from Lactococcus lactis
Pleban, K., Macchiarulo, A., Costantino, G., Pellicciari, R., Chiba, P., & Ecker, G. F. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.09.040 · Cited by 15
Contribution of Efflux to Cefuroxime Resistance in Clinical Isolates of Escherichia coli
Källman, O., Fendukly, F., Karlsson, I., & Kronvall, G. (2003) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540310014639 · Cited by 15
Optimization of antibiotic dosing schedules in the light of increasing antibiotic resistance
Smith, S. V., & Gould, I. M. (2004) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2.2.227 · Cited by 15
In vitro selected fluoroquinolone-resistant mutants of Citrobacter freundii: analysis of the quinolone resistance acquisition
Tavío, M. M., Vilà, J., Ruiz, J., Amicosante, G., Franceschini, N., Martín‐Sánchez, A. M., & Anta, M. T. D. J. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.4.521 · Cited by 15
Quinupristin/dalfopristin
Sanche, S. E., & Blondeau, J. M. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.9.1341 · Cited by 15
Intrinsic Mechanism Decreases Susceptibility ofEscherichia coli O157:H7 to Multiple Antibiotics
Golding, S. S., & Matthews, K. R. (2004) · Journal of Food Protection · doi:10.4315/0362-028x-67.1.34 · Cited by 14
Effects of Macrolides and Ketolides on Mycobacterial Infections
Bermudez, L. E., & Yamazaki, Y. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383241 · Cited by 14
Phenotypic and genotypic characterization of macrolide resistant Streptococcus pneumoniae recovered from adult patients with community-acquired pneumonia in an Argentinian teaching hospital
Bonofiglio, L., Ojeda, M., de Mier, C., Vay, C. A., Famiglietti, A. M. R., Gutkind, G., & Mollerach, M. E. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.10.011 · Cited by 14
Staphylococcus aureus Mutants Isolated via Exposure to Nonfluorinated Quinolones: Detection of Known and Unique Mutations
Roychoudhury, S., Twinem, T. L., Makin, K. M., Nienaber, M. A., Li, C., Morris, T. W., Ledoussal, B., & Catrenich, C. E. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3422-3426.2001 · Cited by 14
Decreased permeability and enhanced proton-dependent active efflux in the development of resistance to quinolones in Morganella morganii
Tavío, M. M., Vilà, J., Ruiz, J., Sánchez, A. M. M., & de Anta, M. T. J. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00117-5 · Cited by 12
Detection of a Novel Tet M Determinant in Tetracycline-Resistant Neisseria gonorrhoeae from Uruguay, 1996–1999
Márquez, C., Dillon, J. R., Rodriguez, V. I., & Borthagaray, G. (2002) · Sexually Transmitted Diseases · doi:10.1097/00007435-200212000-00010 · Cited by 12
Distribution of the antiseptic-resistance genes qacE and qacEΔ1 in Gram-negative bacteria
Kazama, H. (1998) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(97)00563-6 · Cited by 12
Activities of Garenoxacin against Quinolone-Resistant Streptococcus pneumoniae Strains In Vitro and in a Mouse Pneumonia Model
Azoulay-Dupuis, E., Bédos, J. P., Mohler, J., Peytavin, G., Istúriz, R., Moine, P., Rieux, V., Cherbuliez, C., Pechère, J. C., Fantin, B., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.765-773.2004 · Cited by 11
Distribution of the antiseptic-resistance gene qacEΔ1 in Gram-positive bacteria
Kazama, H. (1998) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(98)00291-2 · Cited by 10
Polyclonal Spread of Erythromycin-Resistant Streptococcus agalactiae in Southern Taiwan
Ko, W., Yan, J.-J., Lee, N., Wu, H., & Wu, J. (2004) · Microbial Drug Resistance · doi:10.1089/mdr.2004.10.306 · Cited by 9
Direct sequencing and PCR mapping of integrons reveals multiple class 1 integrons in the multiresistant strainEnterobacter cloacaeSCH88040794
Plante, I., Centrón, D., & Roy, P. H. (2003) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00163-0 · Cited by 9
Activity of ketolide ABT-773 (cethromycin) against erythromycin-resistant Streptococcus pneumoniae: correlation with extended MLSK phenotypes
Hamilton-Miller, J. M. T. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf237 · Cited by 9
In vitro and in vivo Antibacterial Activities of the Tricyclic Ketolide TE‐802 and Its Analogues.
ONO, T., Kashimura, M., Suzuki, K., Oyauchi, R., Miyachi, J., Ikuta, H., Kawauchi, H., Akashi, T., Asaka, T., & Morimoto, S. (2005) · ChemInform · doi:10.1002/chin.200509229 · Cited by 9
Levofloxacin, a Broad Spectrum Anti-infective: from Streptococcus pneumoniae to Pseudomonas aeruginosa
Schito, A. M., & Schito, G. C. (2004) · Journal of Chemotherapy · doi:10.1080/1120009x.2004.11782365 · Cited by 8
Clinically significant borderline resistance of sequential clinical isolates of Klebsiella pneumoniae
Wagenlehner, F. R. A., Heisig, P., Irtenkauf, C., Notka, F., Decker, J., Lehn, N., & Linde, H. ‐. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00126-2 · Cited by 8
Integron Analysis and Genetic Mapping of Antimicrobial Resistance Genes in Salmonella enterica serotype Typhimurium
Daly, M., & Fanning, S. (2004) · Humana Press eBooks · doi:10.1385/1-59259-766-1:015 · Cited by 7
Uninhibited antibiotic target discovery via chemical genetics
Poole, K. (2004) · Nature Biotechnology · doi:10.1038/nbt1204-1528 · Cited by 7
Self-citation
Insertion of a thymine (+T) in the 13 base pair inverted repeat of the Neisseria gonorrhoeae mtr promoter region and antibiotic susceptibility
Cousin, S., Roberts, M. C., & Whittington, W. L. H. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.01.001 · Cited by 6
Prevalence of efflux activity in low-level macrolide-resistant Campylobacter species
Mamelli, L., Demoulin, E., Prouzet‐Mauleon, V., Mégraud, F., Pagès, J., & Bolla, J. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl476 · Cited by 6
Molecular mechanisms of high level tetracycline-resistance in group A streptococcal isolates, T serotypes 4 and 11
Matsumoto, M., Sakae, K., Ohta, M., Endo, M., Okuno, R., Murayama, S., Hirasawa, K., Suzuki, R., Isobe, J., Tanaka, D., et al. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.09.014 · Cited by 5
Activity of five quinolones, three macrolides and telithromycin against 12 Haemophilus influenzae strains with different resistance phenotypes
Pankuch, G. A., Lin, G., & Appelbaum, P. C. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01288.x · Cited by 5
Bacterial Resistance
Poole, K. (2008) · Blackwell Publishing Ltd eBooks · doi:10.1002/9780470755884.ch6b · Cited by 5
Self-citation
Characterization of the antiseptic-resistance gene qacEΔ1 isolated from clinical and environmental isolates of Vibrio parahaemolyticus and Vibrio cholerae non-O1
Kazama, H. (1999) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(99)00167-6 · Cited by 5
In Vitro Development of Resistance to Newer Fluoroquinolones in Streptococcus pneumoniae Isolates with Reduced Susceptibility to Ciprofloxacin
Mayer, S., Boos, M., Köhrer, K., Fluit, A. C., & Schmitz, F. (2001) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/pl00011267 · Cited by 4
Reply
Fraise, A. P. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf070 · Cited by 2

Flagged first, then by citations

Research works printed but not linked: 2

Bartlett JG. 2004 Pocket Book of Infectious Disease Therapy, 12 edn. Baltimore: Lippincott Williams & Wilkins, 2004.
Kumar A, Worobec EA. Cloning sequencing and characterization of the SdeAB multidrug efflux pump of Serratia marcescens. Antimicrob Agents Chemother2005; 49: 1495–1501. · DOI

Sorted by citations

Origins and evolution of antibiotic resistance
Davies, J., & Davies, D. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00016-10 · Cited by 5,784
Mechanisms of Antibiotic Resistance
Munita, J. M., & Arias, C. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0016-2015 · Cited by 2,782
Antimicrobial Resistance: A Growing Serious Threat for Global Public Health
Salam, M. A., Al-Amin, M. Y., Salam, M. T., Pawar, J. S., Akhter, N., Rabaan, A. A., & Alqumber, M. A. A. (2023) · Healthcare · doi:10.3390/healthcare11131946 · Cited by 2,622
Call of the wild: antibiotic resistance genes in natural environments
Allen, H. K., Donato, J., Wang, H. H., Cloud-Hansen, K. A., Davies, J., & Handelsman, J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2312 · Cited by 2,361
Multidrug Resistance in Bacteria
Nikaido, H. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.082907.145923 · Cited by 1,776

See all 1,082

Authors: Poole, K.
Affiliations: Queen's University (CA)
Corresponding author: Poole, Keith
ORCID: Poole, Keith
Venue: Journal of Antimicrobial Chemotherapy
Publisher: Oxford University Press (OUP)
Published: 2005-05-24
Volume: 56
Issue: 1
Pages: 20-51
ISSN: 0305-7453 (ISSN-L)
1460-2091
DOI: 10.1093/jac/dki171
OpenAlex: W2131256712
Cited by: 1,082
References: 733
Citations by year: 2026: 37 · 2025: 50 · 2024: 54 · 2023: 54 · 2022: 43 · 2021: 63 · 2020: 57 · 2019: 52 · 2018: 48 · 2017: 52 · 2016: 70 · 2015: 52 · 2014: 61 · 2013: 57 · 2012: 54
FWCI: 2.24
Type: journal article
Language: en
Open access: closed
Locations: Journal of Antimicrobial Chemotherapy (publishedVersion)
PubMed (publishedVersion)
HighWire Press Open Archive (submittedVersion)
Topics: Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
Keywords: efflux-mediated resistance, antimicrobial resistance, multidrug efflux pumps, biocide resistance, multidrug resistance, plasmid-encoded resistance genes, integrons, transposable elements, mobile genetic elements, efflux pump inhibitors, Gram-negative bacteria, intrinsic resistance, acquired resistance
MeSH terms: Aminoglycosides, Anti-Bacterial Agents, Biological Transport, Chloramphenicol, Tetracycline, Fluoroquinolones, Drug Resistance, Bacterial, Drug Resistance, Multiple, Bacterial

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Efflux-mediated antimicrobial resistance

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks